For additional information, please visit Shareholder Derivative Litigation - Kuehn Law. Attorney advertising. Prior results do not guarantee similar outcomes. Contacts:Kuehn Law, PLLCJustin Kuehn, Esq.53 Hill Street, Suite 605Southampton, NY 11968[email protected](833) 672-0814 SOURCE Kuehn Law, PLLC Accessibility StatementSkip Navigation NEW YORK, Sept. 24, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Petco Health and W ...

Core Viewpoint - Peloton Interactive is required to face a lawsuit alleging that it misled shareholders by concealing excess inventory of home fitness equipment during the easing of COVID-19 restrictions, as ruled by the federal appeals court [1] Summary by Relevant Sections - **Lawsuit Details** - The Manhattan Second Circuit Court overturned a lower court's decision, allowing shareholders to continue their claims against Peloton [1] - The lawsuit claims that Peloton made three false and misleading statements that artificially inflated its stock price [1] - **Stock Performance Context** - The shareholder lawsuit coincides with a period when Peloton's stock price plummeted over 80% from February 5, 2021, to January 19, 2022 [1] - This decline in stock price aligns with the widespread availability of vaccines and the reopening of gyms [1]

Core Viewpoint - UnitedHealth Group is facing a lawsuit for allegedly concealing the negative impact of the killing of its CEO on its business, which led to a significant drop in its stock price after a lowered 2025 profit outlook [1][2]. Group 1: Lawsuit Details - A proposed class action was filed in Manhattan federal court, claiming that shareholders were defrauded following the December 4 shooting of CEO Brian Thompson [2]. - The lawsuit seeks unspecified damages for shareholders from December 3, 2024, to April 16, 2025, with CEO Andrew Witty and CFO John Rex also named as defendants [5]. Group 2: Stock Performance and Financial Impact - UnitedHealth shares plummeted by 22% on April 17, resulting in a loss of approximately $119 billion in market value after the company revised its 2025 adjusted profit per share forecast down to between $26 and $26.50 from a previous range of $29.50 to $30 [3][4]. - The company attributed the lowered forecast to increased costs in its Medicare business, having issued the prior forecast just one day before Thompson's death [4]. Group 3: Allegations of Misleading Information - Shareholders allege that UnitedHealth inflated its stock price by maintaining its old forecast despite growing public backlash and a Senate report on claims denials, which pressured the company to adopt more patient-friendly practices [4][10].